FRPT
Get informed when a big investor buys or sells
+ FollowOvervalued by 126.5% based on the discounted cash flow analysis.
| Market cap | $2.54 Billion |
|---|---|
| Enterprise Value | $2.74 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.85 |
| Beta | 1.73 |
| Outstanding Shares | 49,062,000 |
| P/E Ratio | 12.64 |
|---|---|
| PEG | -2.62 |
| Price to Sales | 2.17 |
| Price to Book Ratio | 2.0 |
| Enterprise Value to Revenue | 2.41 |
| Enterprise Value to EBIT | 28.5 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.46 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7668▼ 97.19% |
|---|---|
| Total Calls | 969,700▲ 26.48% |
| Total Puts | 743,600▼ 44.22% |
Holdings and activity of institutional investors.
| Ownership % | 124.41%▲ 6.09% |
|---|---|
| Total Invested | $3.58B▲ 1.76% |
| Investors Holding | 351▼ 7.00% |
No data
This committee provides the official revenue estimates and technical analysis for all tax legislation, directly influencing corporate tax structures and capital investment credits, which significantly impacts Freshpet's financial performance.
This powerful committee controls taxation and trade policy, both of which directly impact Freshpet's profitability, supply chain costs, and overall market valuation. Decisions here would provide significant insider information.
This committee directly regulates the FDA, which oversees pet food safety, labeling, and ingredients. Additionally, its influence on labor laws directly impacts Freshpet's operational costs and workforce management.